Siemens to close Fast Track Diagnostics by end of year

Siemens Healthineers intends to close its Fast Track Diagnostics unit by September, saying the decline in testing demand from the peak of the pandemic led to the decision.

About 90 employees, mostly based in Luxembourg, will lose their jobs, according to a statement from the company.

Fast Track Diagnostics was launched in 2006, featuring directors from diagnostics firm Laboratoires Réunis, before being acquired by Siemens’ Healthineers subsidiary in 2017. Notably, Fast Track Diagnostics produced Siemens’ SARS-CoV-2 Assay test kits early in the Covid-19 pandemic. While a strategic point of emphasis for the company for obvious reasons at the time, demand for the product, which Siemens primarily sold in Europe, has fallen and PCR testing is a small part of the company’s overall diagnostics portfolio.

“Fast Track Diagnostics is a minor player in the molecular diagnostics space and represents a very small part of the overall revenue of the Siemens Healthineers Diagnostics business,” said the company in contextualizing the decision. 

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Around the web

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.

Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries. 

Heart Rhythm Society President Kenneth A. Ellenbogen, MD, detailed a new advocacy group focused on improving EP reimbursements, patient care and access. “If you’re not at the table, you’re on the menu," he said.